Cargando…

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin

Detalles Bibliográficos
Autores principales: Araki, Shin-ichi, Matsuno, Hiroyuki, Haneda, Masakazu, Koya, Daisuke, Kanno, Yosuke, Kume, Shiniji, Isshiki, Keiji, Araki, Hisazumi, Ugi, Satoshi, Kawai, Hiromichi, Kashiwagi, Atsunori, Uzu, Takashi, Maegawa, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687274/
https://www.ncbi.nlm.nih.gov/pubmed/23801816
http://dx.doi.org/10.2337/dc12-2702
_version_ 1782273894969769984
author Araki, Shin-ichi
Matsuno, Hiroyuki
Haneda, Masakazu
Koya, Daisuke
Kanno, Yosuke
Kume, Shiniji
Isshiki, Keiji
Araki, Hisazumi
Ugi, Satoshi
Kawai, Hiromichi
Kashiwagi, Atsunori
Uzu, Takashi
Maegawa, Hiroshi
author_facet Araki, Shin-ichi
Matsuno, Hiroyuki
Haneda, Masakazu
Koya, Daisuke
Kanno, Yosuke
Kume, Shiniji
Isshiki, Keiji
Araki, Hisazumi
Ugi, Satoshi
Kawai, Hiromichi
Kashiwagi, Atsunori
Uzu, Takashi
Maegawa, Hiroshi
author_sort Araki, Shin-ichi
collection PubMed
description
format Online
Article
Text
id pubmed-3687274
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36872742014-07-01 Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin Araki, Shin-ichi Matsuno, Hiroyuki Haneda, Masakazu Koya, Daisuke Kanno, Yosuke Kume, Shiniji Isshiki, Keiji Araki, Hisazumi Ugi, Satoshi Kawai, Hiromichi Kashiwagi, Atsunori Uzu, Takashi Maegawa, Hiroshi Diabetes Care Online Letters: Observations American Diabetes Association 2013-07 2013-06-12 /pmc/articles/PMC3687274/ /pubmed/23801816 http://dx.doi.org/10.2337/dc12-2702 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Observations
Araki, Shin-ichi
Matsuno, Hiroyuki
Haneda, Masakazu
Koya, Daisuke
Kanno, Yosuke
Kume, Shiniji
Isshiki, Keiji
Araki, Hisazumi
Ugi, Satoshi
Kawai, Hiromichi
Kashiwagi, Atsunori
Uzu, Takashi
Maegawa, Hiroshi
Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
title Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
title_full Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
title_fullStr Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
title_full_unstemmed Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
title_short Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
title_sort cilostazol attenuates spontaneous microaggregation of platelets in type 2 diabetic patients with insufficient platelet response to aspirin
topic Online Letters: Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687274/
https://www.ncbi.nlm.nih.gov/pubmed/23801816
http://dx.doi.org/10.2337/dc12-2702
work_keys_str_mv AT arakishinichi cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT matsunohiroyuki cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT hanedamasakazu cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT koyadaisuke cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT kannoyosuke cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT kumeshiniji cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT isshikikeiji cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT arakihisazumi cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT ugisatoshi cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT kawaihiromichi cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT kashiwagiatsunori cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT uzutakashi cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin
AT maegawahiroshi cilostazolattenuatesspontaneousmicroaggregationofplateletsintype2diabeticpatientswithinsufficientplateletresponsetoaspirin